Relmada Therapeutics, Inc. (RLMD)
NASDAQ·Healthcare·Biotechnology
$5.26
+0.67%
Mkt Cap $545.43M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (6 analysts)
$9.00
Range $8.00 – $10.00
Implied Upside
+71.1%
Consensus $9.00 vs current $5.26
NASDAQ·Healthcare·Biotechnology
$5.26
+0.67%
Mkt Cap $545.43M
Buy
1
Hold
0
Sell
0
Price Target (6 analysts)
$9.00
Range $8.00 – $10.00
+71.1%
Consensus $9.00 vs current $5.26